Reason for request
Inscription
Mise à disposition d'un médicament similaire à TRAVATAN 40 µg/ml, collyre en solution mais formulé sans conservateur.
Clinical Benefit
| Substantial |
Le service médical rendu par VIZITRAV 40 µg/ml, collyre en solution est important dans les indications de l’AMM. |
Clinical Added Value
| no clinical added value |
VIZITRAV 40 µg/ml, collyre en solution n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport à TRAVATAN 40 µg/ml, collyre en solution. |
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
efqKj8Czs32Ff9ws
